M. Alexander Schmidt
Doctor
Infectiology
University of Munster
Germany
Biography
1972-1978: Studies in Chemistry, Universität Freiburg and IC London; 1975-1976 Dr. Carl-Duisberg-Stipend, IC London; 1977: Diploma (DIC) Imperial College of Science & Technology, London; 1982: Graduation Dr. rer nat.; 1982: Otto-Hahn-Medal of the Max-Planck-Society (MPG); 1983-1985: Post-doc with Prof. Dr. Gary K. Schoolnik, Stanford University; 1985-1992: Research Group Leader (Ass. Prof./C3), ZMBH, Universität Heidelberg; 1988: Habilitation in Microbiology, Universität Heidelberg; 1991: Hygiene-Prize of the Rudolf-Schülke Foundation; 1992: Chair Institute of Infectiology, ZMBE, Universität Münster; 1992: Max-von-Pettenkofer Prize; 1999: Distinguished Lectureship (DAAK) UC Berkeley; 2003: Visiting Professor, Department of Public Health, UC Berkeley; 2006: Speaker, International Graduate School GRK1409; 2007: Vice-Dean for Research, Medical Faculty, Universität Münster.
Research Interest
Molecular Biology of Inflammation
Publications
-
Höfling S, Grabowski B, Norkowski S, Schmidt MA, Rüter C (2015) Current activities of the Yersinia effector protein YopM. Int J Med Microbiol 305: 424-432.
-
Starost LJ, Karassek S, Sano Y, Kanda T, Schmidt MA, et al. (2016) Pertussis Toxin Exploits Host Cell Signaling Pathways Induced by Meningitis Causing E. coli K1-RS218 and Enhances Adherence of Monocytic THP-1 Cells to Human Cerebral Endothelial Cells Toxins (Basel) 8: 291.
-
Cordes F, Brückner M, Lenz P, Veltman K, Schmidt MA, et al. (2016) MicroRNA-320a Strengthens Intestinal Barrier Function and Follows the Course of Experimental Colitis. Inflamm Bowel Dis 22: 2341-2355.
-
Sabharwal H, Cichon C, oil beater TA, Sonnenborn U, Schmidt MA (2016) Interleukin-8, CXCL1, and MicroRNA miR-146a Responses to Probiotic Escherichia coli Nissle 1917 and Enteropathogenic E. coli in Human Intestinal Epithelial T84 and Monocytic THP-1 Cells after Apical or Basolateral Infection. Infect Immune 84: 2482-2492.
-
Rüter C, Schmidt MA (2017) Cell-Penetrating Bacterial Effector Proteins: Better Tools than Targets. Trends Biotechnol 35: 109-120.
